SALIX PHARMACEUTICALS LTD Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
SALIX PHARMACEUTICALS LTD had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $1.50 billion as of 2014-01-02, per its 10-Q/A filed 2015-03-02.
Discontinued › Notes › Business Combinations › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2015-03-02
- 2014-01-02: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $1.50B; Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net as first filed $1.54B.
- 2011-12-20: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $342.79M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net as first filed |
|---|---|---|
| 2014-01-02 | $1.50B 10-Q/A · filed 2015-03-02 | $1.54B 10-Q · filed 2014-05-09 |
| 2011-12-20 | $342.79M 10-K · filed 2013-03-01 |